Advertisement

Acquired Bleeding Disorders

  • Thomas G. DeLougheryEmail author
Chapter

Abstract

This chapter covers common acquired bleeding disorders such as thrombocytopenia due to illness or drugs and coagulation factor inhibitors. The most common bleeding disorders in older patients are acquired bleeding disorders. The most frequent, immune thrombocytopenia, liver and renal disease, and DIC, are discussed in other chapters. This chapter reviews other causes of acquired bleeding disorders.

Keywords

Brodifacoum Factor inhibitors Platelet dysfunction Vitamin K deficiency 

Suggested Reading

  1. Alberio L. My patient is thrombocytopenic! Is (s)he? Why? And what shall I do? A practical approach to thrombocytopenia. Hamostaseologie. 2013;33(2):83–94.CrossRefGoogle Scholar
  2. Al-Nouri ZL, George JN. Drug-induced thrombocytopenia: an updated systematic review, 2012. Drug Saf. 2012;35(8):693–4.CrossRefGoogle Scholar
  3. Charlebois J, Rivard GÉ, St-Louis J. Management of acquired von Willebrand syndrome. Transfus Apher Sci. 2018;57(6):721–3.  https://doi.org/10.1016/j.transci.2018.10.012. Epub 2018 Oct 30.CrossRefPubMedGoogle Scholar
  4. Coppola A, Favaloro EJ, Tufano A, Di Minno MN, Cerbone AM, Franchini M. Acquired inhibitors of coagulation factors: part I-acquired hemophilia A. Semin Thromb Hemost. 2012;38(5):433–46.CrossRefGoogle Scholar
  5. Feinstein DL, Akpa BS, Ayee MA, Boullerne AI, Braun D, Brodsky SV, Gidalevitz D, Hauck Z, Kalinin S, Kowal K, Kuzmenko I, Lis K, Marangoni N, Martynowycz MW, Rubinstein I, van Breemen R, Ware K, Weinberg G. The emerging threat of superwarfarins: history, detection, mechanisms, and countermeasures. Ann N Y Acad Sci. 2016;1374(1):111–22.CrossRefGoogle Scholar
  6. Franchini M, Lippi G, Favaloro EJ. Acquired inhibitors of coagulation factors: part II. Semin Thromb Hemost. 2012;38(5):447–53.CrossRefGoogle Scholar
  7. Kruse-Jarres R, Kempton CL, Baudo F, Collins PW, Knoebl P, Leissinger CA, Tiede A, Kessler CM. Acquired hemophilia A: updated review of evidence and treatment guidance. Am J Hematol. 2017;92(7):695–705.  https://doi.org/10.1002/ajh.24777. Epub 2017 Jun 5.CrossRefPubMedGoogle Scholar
  8. Loo AS, Gerzenshtein L, Ison MG. Antimicrobial drug-induced thrombocytopenia: a review of the literature. Semin Thromb Hemost. 2012;38(8):818–29.CrossRefGoogle Scholar
  9. Mitta A, Curtis BR, Reese JA, George JN. Drug-induced thrombocytopenia: 2019 Update of clinical and laboratory data. Am J Hematol. 2019;94(3):E76–8.PubMedGoogle Scholar
  10. Scharf RE. Drugs that affect platelet function. Semin Thromb Hemost. 2012;38(8):865–83.CrossRefGoogle Scholar
  11. Tiede A, Rand JH, Budde U, Ganser A, Federici AB. How I treat the acquired von Willebrand syndrome. Blood. 2011;117(25):6777–85.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Division of Hematology/Medical Oncology, Department of Medicine, Pathology, and PediatricsOregon Health & Sciences UniversityPortlandUSA

Personalised recommendations